Johnson & Johnson (JNJ) Non-Current Debt (2009 - 2026)

Johnson & Johnson (JNJ) posted Non-Current Debt of $37.5 billion for Q1 2026, down 4.85% sequentially from $39.4 billion in Q4 2025, and down 2.16% YoY from $38.4 billion in Q1 2025.

Johnson & Johnson (JNJ) Non-Current Debt (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Non-Current Debt data on file, last reported at $37.5 billion in Q1 2026.

  • Quarterly Non-Current Debt fell 2.16% year-over-year to $37.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.5 billion (down 2.16% YoY) and the FY2025 annual result came in at $39.4 billion, up 28.67% from the prior year.
  • Non-Current Debt retreated to $37.5 billion in Q1 2026 per JNJ's latest filing, from $39.4 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $39.4 billion in Q4 2025, with the low at $25.1 billion in Q1 2024.
  • Average Non-Current Debt over 5 years is $31.9 billion, with a median of $31.0 billion recorded in 2024.
  • Year-over-year, Non-Current Debt fell 28.19% in 2024 and surged 52.92% in 2025.
  • Johnson & Johnson's Non-Current Debt stood at $27.6 billion in 2022, then fell by 6.24% to $25.9 billion in 2023, then advanced by 18.43% to $30.7 billion in 2024, then increased by 28.67% to $39.4 billion in 2025, then decreased by 4.85% to $37.5 billion in 2026.
  • Business Quant data shows JNJ's Non-Current Debt at $37.5 billion in Q1 2026, $39.4 billion in Q4 2025, and $39.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 39.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 37.53 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 64.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -24.45 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 46.67 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 20.86 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 60.57 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 37.53 Bn
Dec 28, 2025 39.44 Bn
Sep 28, 2025 39.41 Bn
Jun 29, 2025 39.24 Bn
Mar 30, 2025 38.36 Bn
Dec 29, 2024 30.65 Bn
Sep 29, 2024 31.29 Bn
Jun 30, 2024 31.64 Bn
Mar 31, 2024 25.08 Bn
Dec 31, 2023 25.88 Bn
Oct 1, 2023 26.05 Bn
Jul 2, 2023 33.90 Bn
Apr 2, 2023 34.93 Bn
Jan 1, 2023 26.89 Bn
Oct 2, 2022 27.60 Bn
Jul 3, 2022 28.29 Bn
Apr 3, 2022 28.85 Bn
Jan 2, 2022 29.99 Bn
Oct 3, 2021 30.13 Bn
Jul 4, 2021 30.31 Bn